Shopping Cart 0
Cart Subtotal
AED 0

Hemostasis Products Market (Topical Hemostasis, Infusible Hemostasis and Advanced Hemostasis) for Trauma, Surgery, Hemophilia, Myocardial Infarction, Stroke, and Thrombosis Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 15410

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 23117

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 30824
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

The report covers forecast and analysis for the hemostasis products market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Billion). The study includes drivers and restraints for the hemostasis products market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hemostasis products market on a global level. In order to give the users of this report a comprehensive view on the hemostasis products market, we have to include competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness. The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new product launch, agreements, partnerships, collaborations joint ventures, research development, product and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies along with patent analysis (2011-2016) bifurcated into the patent trend, patent share by company and patent analysis according to the region. The study provides a decisive view on the hemostasis products market by segmenting the market based on products, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Based on products the market is segmented into topical hemostasis, infusible hemostasis, and advanced hemostasis. Key application market covered under this study includes trauma, surgery, hemophilia, myocardial infarction, stroke, and thrombosis. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for hemostasis products based on individual product and applications in all the regions and countries. The report also includes detailed profiles of end players such as Pfizer, Inc., Medtronic plc, Abbott Laboratories, Johnson Johnson, Integra LifeSciences Corporation, HemCon Medical Technologies, Inc., Grifols, S.A., CSL Behring LLC, C. R. Bard, Inc. and Baxter International, Inc. This report segments the global hemostasis products market as follows: Global Hemostasis Products Market: Product Segment Analysis Topical Hemostasis Collagen Oxidized Regenerated Cellulose Gelatin Polysaccharide Infusible Hemostasis Platelet Concentrates from Donor Blood FVIII Derived from Blood Fresh Frozen Plasma Prothrombin Complex Advanced Hemostasis Flowable Thrombin Fibrin Synthetic Sealants Global Hemostasis Products Market: Application Segment Analysis Trauma Surgery Hemophilia Myocardial Infarction Stroke Thrombosis Global Hemostasis Products Market: Regional Segment Analysis North America U.S. Europe Germany France UK Asia Pacific China Japan India Latin America Brazil Middle East Africa

READ MORE

Table Of Content

Scope

Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global hemostasis products market, 2015 2021 (USD Billion) 2.2. Global hemostasis products market : Snapshot Chapter 3. Hemostasis Products Market Dynamics 3.1. Introduction 3.2. Market drivers 3.2.1. Global hemostasis products market drivers: Impact 3.2.2. Increasing number of trauma and surgical cases 3.3. Market restraints 3.3.1. Global hemostasis products market restraints: Impact analysis 3.3.2. Stringent regulatory policies 3.4. Opportunities 3.4.1. Emerging market in developing countries 3.5. Porters five forces analysis 3.5.1. Bargaining power of suppliers 3.5.2. Bargaining power of buyers 3.5.3. Threat from new entrants 3.5.4. Threat from new substitutes 3.5.5. Degree of competition 3.6. Market attractiveness analysis 3.6.1. Market attractiveness analysis, by product segment 3.6.2. Market attractiveness analysis, by application segment 3.6.3. Market attractiveness analysis, by regional segment Chapter 4. Global Hemostasis Products Market Competitive Landscape 4.1. Company Market Share Analysis(Subject to data Availability) 4.1.1. Global hemostasis products market: company market share, 2015 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Product Launch 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures 4.2.4. Research and Development, Product and Regional Expansion Chapter 5. Global Hemostasis Products Market Product Segment Analysis 5.1. Global hemostasis products market: Product overview 5.1.1. Global hemostasis products market revenue share, by product, 2015 and 2021 5.2. Topical Hemostasis 5.2.1. Global topical hemostasis market , 2015 2021(USD Billion) 5.3. Infusible hemostasis 5.3.1. Global infusible hemostasis market , 2015 2021(USD Billion) 5.4. Advanced Hemostasis 5.4.1. Global advanced hemostasis market , 2015 2021(USD Billion) Chapter 6. Global Hemostasis Products Market Application Segment Analysis 6.1. Global hemostasis products market: Application overview 6.1.1. Global hemostasis products market revenue share, by application, 2015 and 2020 6.2. Trauma 6.2.1. Global hemostasis products market for trauma, 2015 2021 (USD Billion) 6.3. Surgery 6.3.1. Global hemostasis products market for surgery, 2015 2021(USD Billion) 6.4. Hemophilia 6.4.1. Global hemostasis products market for hemophilia, 2015 2021 (USD Billion) 6.5. Myocardial infarction 6.5.1. Global hemostasis products market for myocardial infarction, 2015-2021(USD Billion) 6.6. Stroke 6.6.1. Global hemostasis products market for stroke, 2015-2021(USD Billion) 6.7. Thrombosis 6.7.1. Global hemostasis products market for thrombosis, 2015 2021 (USD Billion) Chapter 7. Global Hemostasis Products Market Regional Segment Analysis 7.1. Global hemostasis products market: Regional overview 7.1.1. Global hemostasis products market revenue share, by region, 2015 and 2021 7.2. North America 7.2.1. North America hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.2.2. North America hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.2.3. U.S. 7.2.3.1. U.S. hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.2.3.2. U.S. hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.3. Europe 7.3.1. Europe hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.3.2. Europe hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.3.3. Germany 7.3.3.1. Germany hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.3.3.2. Germany hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.3.4. France 7.3.4.1. France hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.3.4.2. France hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.3.5. UK 7.3.5.1. UK hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.3.5.2. UK hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.4. Asia Pacific 7.4.1. Asia Pacific hemostasis products market revenue, by product, 2015 2021, (USD Billion) 7.4.2. Asia Pacific hemostasis products market revenue, by application, 2015 2021, (USD Billion) 7.4.3. China 7.4.3.1. China hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.4.3.2. China hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.4.4. Japan 7.4.4.1. Japan hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.4.4.2. Japan hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.4.5. India 7.4.5.1. India hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.4.5.2. India hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.5. Latin America 7.5.1. Latin America hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.5.2. Latin America hemostasis products market revenue, by application, 2015 2021(USD Billion) 7.5.3. Brazil 7.5.3.1. Brazil hemostasis products market revenue, by product, 2015 2021(USD Billion) 7.5.3.2. Brazil hemostasis products market revenue, by application, 2015 2021 (USD Billion) 7.6. Middle East and Africa 7.6.1. Middle East and Africa hemostasis products market revenue, by product, 2015 2021 (USD Billion) 7.6.2. Middle East and Africa hemostasis products market revenue, by application, 2015 2021(USD Billion) Chapter 8. Company Profile 8.1. Pfizer, Inc. 8.1.1. Overview 8.1.2. Financials 8.1.3. Product portfolio 8.1.4. Business strategy 8.1.5. Recent developments 8.2. Medtronic plc 8.2.1. Overview 8.2.2. Financials 8.2.3. Product portfolio 8.2.4. Business strategy 8.2.5. Recent developments 8.3. Abbott Laboratories 8.3.1. Overview 8.3.2. Financials 8.3.3. Product portfolio 8.3.4. Business strategy 8.3.5. Recent developments 8.4. Johnson Johnson 8.4.1. Overview 8.4.2. Financials 8.4.3. Product portfolio 8.4.4. Business strategy 8.4.5. Recent developments 8.5. Integra LifeSciences Corporation 8.5.1. Overview 8.5.2. Financials 8.5.3. Product portfolio 8.5.4. Business strategy 8.5.5. Recent developments 8.6. HemCon Medical Technologies, Inc. 8.6.1. Overview 8.6.2. Financials 8.6.3. Product portfolio 8.6.4. Business strategy 8.6.5. Recent developments 8.7. Grifols, S.A. 8.7.1. Overview 8.7.2. Financials 8.7.3. Product portfolio 8.7.4. Business strategy 8.7.5. Recent developments 8.8. CSL Behring LLC 8.8.1. Overview 8.8.2. Financials 8.8.3. Product portfolio 8.8.4. Business strategy 8.8.5. Recent developments 8.9. C. R. Bard, Inc. 8.9.1. Overview 8.9.2. Financials 8.9.3. Product portfolio 8.9.4. Business strategy 8.9.5. Recent developments 8.10. Baxter International, Inc. 8.10.1. Overview 8.10.2. Financials 8.10.3. Product portfolio 8.10.4. Business strategy 8.10.5. Recent developments

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com